𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Sexual functioning in depressed outpatients taking mirtazapine

✍ Scribed by Beth K. Boyarsky; Waheedul Haque; Mark R. Rouleau; Robert M.A. Hirschfeld


Publisher
John Wiley and Sons
Year
1999
Tongue
English
Weight
124 KB
Volume
9
Category
Article
ISSN
1091-4269

No coin nor oath required. For personal study only.

✦ Synopsis


Objectives-One-third of patients with untreated depression have sexual difficulties manifested by decreased libido, erectile dysfunction or delayed ejaculation. This dysfunction may be exacerbated by stimulation of post-synaptic serotonin 5HT2 receptors, a side-effect of most widely-used antidepressant medications, especially the selective serotonin reuptake inhibitors (SSRIs). Mirtazapine is an atypical antidepressant with a2 adrenergic antagonist and serotonin 5-HT2 and 5-HT3 receptor-blocking activity. In theory, it should not worsen and perhaps may improve sexual function. This pilot study investigated sexual functioning and antidepressant activity in depressed patients taking mirtazapine. Experimental design-Twenty-five (F = 18, M = 7) sexually active adult outpatients with a DSM-IV-diagnosis of major depressive episode entered a 12-week, flexible-dosing, open-label pilot study. The Arizona Sexual Experiences Scale (ASEX) assessed sexual functioning and the Hamilton Depression Rating Scale (HAM-D) assessed depressive symptoms on a bimonthly basis. Principal Observations-Desire, arousal/lubrication, and ease/satisfaction of orgasm improved (by 41%, 52%, and 48%, respectively) in the depressed women. In men, desire, arousal/erection, and ease/satisfaction of orgasm also improved (by 10%, 23% and 14%, respectively) but much more modestly. HAM-D, Clinical Global Impression (CGI) Sheehan Disability Scale (SDS), and Symptom Checklist-90 (SCL-90) scores improved in both groups.

There was a 50% dropout rate among women before six weeks of treatment. However, the ASEX and HAM-D scores of the groups terminating before and after six weeks of treatment showed similar rates of improvement.

Conclusions-Mirtazapine has a beneficial effect on sexual functioning in both depressed women and men. Longer-term double-blind research assessing sexual function during the administration of mirtazapine as well as other antidepressants is recommended.


πŸ“œ SIMILAR VOLUMES


Assessment of sexual functioning in depr
✍ JerΓ³nimo Saiz-Ruiz; Jose Manuel Montes; Ángela IbÑñez; Marina DΓ­az; Francisco Vi πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 71 KB

Antidepressant-induced sexual dysfunction is a frequent side effect which may greatly contribute to treatment non compliance. Mirtazapine has a pharmacological profile expected to result in a lack of sexual dysfunction. The main purpose of this 6-month open-label study was to evaluate the effects of

Mirtazapine augmentation in depressed pa
✍ Nahit Kamil Ozmenler; Tunay Karlidere; Ali Bozkurt; Sinan Yetkin; Ali Doruk; Lev πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 74 KB πŸ‘ 1 views

## Abstract ## Objective To evaluate the effect of mirtazapine augmentation in patients with sexual dysfunction induced by current selective serotonin reuptake inhibitor (SSRI) treatment. ## Methods Forty‐nine outpatients in remission from major depressive disorder with SSRI treatment and experi

Childhood emotional, physical, and sexua
✍ Brandon E. Gibb; Iwona Chelminski; Mark Zimmerman πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 139 KB πŸ‘ 1 views

Although a number of theorists have hypothesized a link between negative experiences during childhood (e.g., abuse) and the presence of psychopathology in adults, little is known about the relative specificity of childhood emotional, physical, or sexual abuse to different forms of psychopathology. I

The influence of trazodone treatment on
✍ Wim J. Riedel; Els Schoenmakers; Annemiek Vermeeren; James F. O'Hanlon πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 187 KB πŸ‘ 3 views

Eight patients suering from major depression were treated with trazodone 150 or 200 mg bid (non-responders) over 5 weeks, preceded and followed by a placebo week. Cognitive functioning was tested in the morning at the end of each treatment week. Before trazodone treatment commenced, patients' cognit